NCT07398391 Blood Pressure Care for Advancing Real-World Evidence (BPCARE) Status RECRUITING Phase NA
NCT07396220 Psychotherapy Combined With Intranasal Esketamine for the Treatment of Suicidal Ideation Status ENROLLING_BY_INVITATION Phase NA
NCT07369089 Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement Status NOT_YET_RECRUITING Phase PHASE2
NCT07364071 Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07346209 Real-world Trial of Individualized Precision Oncology Status NOT_YET_RECRUITING Phase PHASE2
NCT07342543 Guided Physical Activity Counseling for Hypertension in Primary Care Status NOT_YET_RECRUITING Phase NA
NCT07336355 Feasibility of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Knee Surgery Status WITHDRAWN Phase NA
NCT07305363 Seladelpar in Adult Liver Transplant Recipients With Ischemic Cholangiopathy (SELIC). Status NOT_YET_RECRUITING Phase PHASE2
NCT07282951 Strong Evidence: Digitally Delivered Exercise in Older Adults Status ACTIVE_NOT_RECRUITING Phase NA
NCT07282782 A Prospective, Randomized Parallel Group Study of the Efficacy of Vancomycin Administered Through Intraarticular Injection Versus Intraosseous Injection Versus Intravenous Infusion in Patients Undergoing Total Knee Arthroplasty Status RECRUITING Phase PHASE4
NCT07280897 SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial Status NOT_YET_RECRUITING Phase NA
NCT07280598 Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections Status NOT_YET_RECRUITING Phase PHASE1
NCT07264283 The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31 Status NOT_YET_RECRUITING Phase PHASE2
NCT07255781 Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy Status WITHDRAWN Phase N/A
NCT07227233 Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer. Status RECRUITING Phase PHASE2